Table 3 Clinical tumor staging of group B by PET CT scan pre- and post-therapeutic. Data are numbers (N) and percentages (%)
Variable | Â | N | % |
|---|---|---|---|
Clinical tumor stage before treatment by PET CT scan | Clinical T2-T4a/ N2-N3/M0 | 17 | 100 |
Clinical tumor stage after treatment by PET CT scan | Clinical T2/N0/M0 | 2 | 11.8 |
Clinical T2/N1/Mo | 3 | 17.6 | |
Clinical T3-T4a/N0-N1/M0 | 6 | 35.3 | |
Clinical T2-T4a/N2-N3/M0 | 3 | 17.6 | |
Clinical T4b/N1–3/M0 | 2 | 11.8 | |
Any T/Any N/M1 | 1 | 5.9 | |
Response of the tumor as assessed by PET/CT pre- and post-treatment | Response | 11 | 64.7 |
Stationary | 3 | 17.6 | |
Upstaged | 3 | 17.6 |